Submitted by Anonymous (not verified) on 2 August 2024 - 10:26
Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 41, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 41, Status: Authorised